← Back to headlines
Braveheart Bio and Attovia seek significant funds in U.S. IPOs
Braveheart Bio and Attovia are reportedly seeking to raise $275 million and $182 million, respectively, through their initial public offerings in the U.S. market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
